TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 108 filers reported holding TRICIDA INC in Q1 2021. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,012 | -98.5% | 13,158 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $138,000 | +8.7% | 13,158 | 0.0% | 0.04% | +20.0% |
| Q2 2022 | $127,000 | +17.6% | 13,158 | 0.0% | 0.03% | +42.9% |
| Q1 2022 | $108,000 | -14.3% | 13,158 | 0.0% | 0.02% | -4.5% |
| Q4 2021 | $126,000 | +106.6% | 13,158 | 0.0% | 0.02% | +83.3% |
| Q3 2021 | $61,000 | +7.0% | 13,158 | 0.0% | 0.01% | +9.1% |
| Q2 2021 | $57,000 | -18.6% | 13,158 | 0.0% | 0.01% | -15.4% |
| Q1 2021 | $70,000 | -24.7% | 13,158 | 0.0% | 0.01% | -27.8% |
| Q4 2020 | $93,000 | -21.8% | 13,158 | 0.0% | 0.02% | -30.8% |
| Q3 2020 | $119,000 | -67.1% | 13,158 | 0.0% | 0.03% | -69.8% |
| Q2 2020 | $362,000 | +25.3% | 13,158 | 0.0% | 0.09% | +11.7% |
| Q1 2020 | $289,000 | -41.9% | 13,158 | 0.0% | 0.08% | -26.0% |
| Q4 2019 | $497,000 | +22.4% | 13,158 | 0.0% | 0.10% | +10.6% |
| Q3 2019 | $406,000 | -21.8% | 13,158 | 0.0% | 0.09% | -19.0% |
| Q2 2019 | $519,000 | +2.2% | 13,158 | 0.0% | 0.12% | -0.9% |
| Q1 2019 | $508,000 | +63.9% | 13,158 | 0.0% | 0.12% | +41.0% |
| Q4 2018 | $310,000 | -22.9% | 13,158 | 0.0% | 0.08% | -8.8% |
| Q3 2018 | $402,000 | +2.3% | 13,158 | 0.0% | 0.09% | -6.2% |
| Q2 2018 | $393,000 | – | 13,158 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |